publication venue for
- Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.. 50-55. 2024
- The activity advantage: Objective measurement of preoperative activity is associated with postoperative recovery and outcomes in patients undergoing surgery with gynecologic oncologists.. 137-143. 2024
- Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists.. 43-50. 2024
- In the patient's shoes: The impact of hospital proximity and volume on stage I endometrial cancer care patterns and outcomes.. 91-98. 2024
- Use of topic modeling to assess research trends in the journal Gynecologic Oncology.. 41-46. 2023
- Promoting timely goals of care conversations between gynecologic cancer patients at high-risk of death and their providers.. 164:288-294. 2021
- Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway.. 163:191-198. 2021
- Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.. 163:41-49. 2021
- The effect of frailty on postoperative readmissions, morbidity, and mortality in endometrial cancer surgery.. 161:353-360. 2021
- Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.. 160:477-484. 2020
- Discrepancies between author- and industry-reported disclosures of financial relationships at an annual gynecologic oncology research meeting.. 160:260-264. 2020
- Natural language processing with machine learning to predict outcomes after ovarian cancer surgery.. 160:182-186. 2020
- Risk factors for potentially avoidable readmissions following gynecologic oncology surgery.. 159:195-200. 2020
- Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival.. 158:331-338. 2020
- Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.. 153:41-48. 2019
- Benign hysterectomy performed by gynecologic oncologists: Is selection bias altering our ability to measure surgical quality?. 151:141-144. 2018
- Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility.. 149:401-409. 2018
- Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.. 149:394-400. 2018
- Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.. 148:329-335. 2017
- Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?. 147:607-611. 2017
- Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?. 146:368-372. 2017
- Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.. 145:500-507. 2017
- Prevention of venous thromboembolism in gynecologic oncology surgery.. 144:420-427. 2016
- Association between hypoalbuminemia and surgical site infection in vulvar cancers.. 142:435-9. 2016
- Who presents satisfied? Non-modifiable factors associated with patient satisfaction among gynecologic oncology clinic patients.. 142:299-303. 2016
- Corrigendum to 'A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery' Gynecol. Oncol. 139 (2015) start 401-406.. 142:-. 2016
- The health-related quality of life journey of gynecologic oncology surgical patients: Implications for the incorporation of patient-reported outcomes into surgical quality metrics.. 141:329-335. 2016
- A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery.. 139:401-6. 2015
- Venous thromboembolism in gynecologic surgery: Are we any closer to determining an optimal prophylaxis regimen?. 138:495-6. 2015
- Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.. 131:714-9. 2013
- The significance of perineural invasion in early-stage cervical cancer.. 123:561-4. 2011
- Involvement in decision-making about treatment and ovarian cancer survivor quality of life.. 124:465-70. 2011